V. Craig Jordan

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?”.

50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened?

Endocrine Related Cancer(2020)10.1530/erc-20-0335

N/A

0DataRank · unranked

50 citations

V. Craig Jordan

Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer

Exploration of Targeted Anti-tumor Therapy(2020)10.37349/etat.2020.00021

N/A

0DataRank · unranked

7 citations

Michele Cummings, Abeer M. Shaaban, Balkees Abderrahman, Mark A. Hull, Philipp Y. Maximov +7 more

Serendipity in the search for “morning-after pills” led to clomiphene for the induction of ovulation

F&S Science(2020)10.1016/j.xfss.2020.07.002

N/A

0DataRank · unranked

2 citations

V. Craig Jordan

PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-21-0702

N/A

0DataRank · unranked

52 citations

V. Craig Jordan, Ping Fan